This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1988 Apr 30;1(8592):1000-1.

doi: 10.1016/s0140-6736(88)91823-5.

Cannabis and schizophrenia

S Andréasson, P Allebeck, A Engström, U Rydberg

PMID: 2896812
DOI: 10.1016/s0140-6736(88)91823-5

Cannabis and schizophrenia

S Andréasson et al. Lancet. 1988.

. 1988 Apr 30;1(8592):1000-1.

doi: 10.1016/s0140-6736(88)91823-5.

Authors

S Andréasson, P Allebeck, A Engström, U Rydberg

PMID: 2896812
DOI: 10.1016/s0140-6736(88)91823-5

No abstract available

PubMed Disclaimer

Similar articles

[Cannabis use as a probable causative factor in the later development of schizophrenia].
Smit F, Bolier L, Cuijpers P. Smit F, et al. Ned Tijdschr Geneeskd. 2003 Nov 1;147(44):2178-83. Ned Tijdschr Geneeskd. 2003. PMID: 14626837 Dutch.
[Does cannabis use lead to schizophrenia?].
Heekeren K. Heekeren K. Praxis (Bern 1994). 2011 Nov 2;100(22):1361-7. doi: 10.1024/1661-8157/a000714. Praxis (Bern 1994). 2011. PMID: 22048912 Review. German.
Cannabis use and the risk of later schizophrenia: a review.
Smit F, Bolier L, Cuijpers P. Smit F, et al. Addiction. 2004 Apr;99(4):425-30. doi: 10.1111/j.1360-0443.2004.00683.x. Addiction. 2004. PMID: 15049742 Review.
[Cannabis and schizophrenia: what risks?].
Krebs MO. Krebs MO. Rev Prat. 2013 Mar;63(3):332-3. Rev Prat. 2013. PMID: 23687755 French. No abstract available.
Cannabis, cannabinoids and schizophrenia: integration of the evidence.
Cohen M, Solowij N, Carr V. Cohen M, et al. Aust N Z J Psychiatry. 2008 May;42(5):357-68. doi: 10.1080/00048670801961156. Aust N Z J Psychiatry. 2008. PMID: 18473254 Review.

See all similar articles

Cited by

Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
Auther AM, McLaughlin D, Carrión RE, Nagachandran P, Correll CU, Cornblatt BA. Auther AM, et al. Psychol Med. 2012 Dec;42(12):2485-97. doi: 10.1017/S0033291712000803. Epub 2012 Apr 30. Psychol Med. 2012. PMID: 22716931 Free PMC article.
Psychosis risk as a function of age at onset: a comparison between early- and late-onset psychosis in a general population sample.
Köhler S, van Os J, de Graaf R, Vollebergh W, Verhey F, Krabbendam L. Köhler S, et al. Soc Psychiatry Psychiatr Epidemiol. 2007 Apr;42(4):288-94. doi: 10.1007/s00127-007-0171-6. Epub 2007 Mar 12. Soc Psychiatry Psychiatr Epidemiol. 2007. PMID: 17370045 Free PMC article.
Substance use in clinical high risk for psychosis: a review of the literature.
Addington J, Case N, Saleem MM, Auther AM, Cornblatt BA, Cadenhead KS. Addington J, et al. Early Interv Psychiatry. 2014 May;8(2):104-12. doi: 10.1111/eip.12100. Epub 2013 Nov 14. Early Interv Psychiatry. 2014. PMID: 24224849 Free PMC article. Review.
Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.
Lafourcade M, Elezgarai I, Mato S, Bakiri Y, Grandes P, Manzoni OJ. Lafourcade M, et al. PLoS One. 2007 Aug 8;2(8):e709. doi: 10.1371/journal.pone.0000709. PLoS One. 2007. PMID: 17684555 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information